MedTrace Logo

Analgesic Effects of Cannabidiol for Simple Tooth Extractions in Dental Patients

NCT04271917 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2022-05-02

No results posted yet for this study

Summary

The purpose of this study is to evaluate the analgesic effects of cannabidiol for patients who have undergone simple tooth extraction. Participants will be randomized to one of four arms: treatment-as-usual (TAU), cannabidiol 17mg/mL, cannabidiol 37mg/mL, or placebo.

Conditions

  • Pain, Acute

Interventions

DRUG

cannabidiol

Use of cannabidiol as an alternative to standard of care treatment of acute pain.

DRUG

placebo

Inactive placebo oil to imitate CBD oil

DRUG

acetaminophen 500mg and ibuprofen 200mg combo

standard of care

Sponsors & Collaborators

  • University of Tennessee

    lead OTHER

Principal Investigators

  • Karen J Derefinko, PhD · University of Tennessee

  • Ammaar H Abidi, DDS, PhD · University of Tennessee

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-24
Primary Completion
2022-03-31
Completion
2022-03-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04271917 on ClinicalTrials.gov